Zahabia Adnan: Meta-Analysis Supports Rivaroxaban as an Effective Option for Cancer-Associated VTE
Zahabia Adnan, Research Executive at Student Research Form-SMC, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Clinical and Applied Thrombosis/Hemostasis, adding:
“I’m pleased to share our recently published systematic review and meta-analysis, ‘Rivaroxaban versus Low Molecular Weight Heparin for Cancer-Associated Venous Thromboembolism,’ in Clinical and Applied Thrombosis/Hemostasis.
Analyzing data from 25 studies and 19,153 patients, our findings indicate that rivaroxaban was associated with a significant reduction in both VTE recurrence and all-cause mortality compared to low molecular weight heparin in patients with cancer-associated thrombosis.
These results contribute to the evolving evidence on anticoagulant selection in oncology and highlight the need for continued large-scale trials.
I’m grateful for the invaluable contributions of my co-authors for making this project successful.
Hoping to work on more projects too.
Do give a read to it.”
Title: Rivaroxaban versus Low Molecular Weight Heparin for Cancer-Associated Venous Thromboembolism: A Systematic Review and Meta-Analysis
Authors: Zahabia Adnan, Syed Ibad Hussain, Amna Amir Jalal, Ayesha Shaukat, Eisha Abid, Muhammad Burhan, Arsalan Ahmed, Eshal Saghir, Shaikh Muhammad Daniyal, Shanza Shakir, Abedin Samadi, Ahmed Asad Raza
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 18, 2026, 15:29Santagata Davide: Timely Removal of Retrievable IVC Filters May Reduce VTE Recurrence and Mortality
-
Jun 18, 2026, 15:13Youssef Afifi: The Thrombocytosis–Bleeding Paradox
-
Jun 18, 2026, 15:06Nihala Sharin E A: The Vital Role of Hematology in the Medical Laboratory
-
Jun 18, 2026, 14:59Maeve Crowley: Shining a Light on Venous Thromboembolism Trends in Ireland
-
Jun 18, 2026, 14:52Samwel Mikaye: Why Early Recognition of Pulmonary Embolism Matters
-
Jun 18, 2026, 14:34Alec van Gelder: From Crisis Care to Continuous Care in SCD
-
Jun 18, 2026, 14:17Charlotte Aubin: A New Perspective on BDNF’s Influence on Hemostasis and Thrombotic Risk
-
Jun 18, 2026, 14:01Heghine Khachatryan: Improving Long-Term Outcomes in PE Through Mechanical Thrombectomy
-
Jun 18, 2026, 13:55Shumaila Ishad: Acute Coronary Syndrome – When Every Minute Matters